Interestingly, genomic alterations in the 3’UTR region of the PD-L1 gene itself have an impact on the PD-L1 expression in some cancers[90], which may indicate a shared TTP regulation mechanism of the PD-L1 mRNA, as it is the case in K-RAS mut cancers. The gene discussed is KRAS; the disease is cancer.